Purchase this article with an account.
Domenico Schiano Lomoriello, Laura Tranchina, Luca Iacobelli, Marco Lombardo, Luca Gualdi, Domenico Amato, Pietro Ducoli; Preliminary Study For Assessing The Safety and Efficacy Of The AcrySof Cachet Phakic Angle-Supported Intraocular Lens. Invest. Ophthalmol. Vis. Sci. 2011;52(14):6188.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To assess the safety and effectiveness of the AcrySof phakic angle-supported intraocular lens (Cachet pIOL, Alcon Laboratories, Inc., Fort Worth, TX) for correction of moderate to high myopia in adults.
19 eyes of 10 patients with moderate to high myopia were implanted with an AcrySof Cachet pIOL. Manifest refraction spherical equivalent (MRSE), uncorrected distance visual acuity (UCVA) and best spectacle-corrected visual acuity (BSCVA) and endothelial cell density (ECD) were evaluated both preoperatively and 6-months postoperatively.
Mean (±SD) age of the population study was 38.26 (±8.98) years old. The mean preoperative MRSE was -9.49 ± 3.08 diopters (D; range -6.00 to -16.75 D). The 6-months postoperative mean MRSE was -0.29 D (± 0.41; P<0.001). The mean (±SD) preoperative and 6-months postoperative ECD were 2829 ± 301 cell/mm2 and 2902 ± 334 cell/mm2 respectively (P=0.67). No iridotomy was performed preoperatively. No pupil ovalization or pupillary block were observed postoperatively.
The AcrySof phakic angle-supported IOL yielded excellent refractive correction and predictability for the correction of moderate and high myopia, with no change in ECD count during a 6-months follow-up.
This PDF is available to Subscribers Only